| RS529866697 |
SMAD6
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic valve disease 2, Inborn genetic diseases |
| RS529868327 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Susceptibility to mononeuropathy of the median nerve, mild |
| RS529873727 |
KIDINS220
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS529884745 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS529885772 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Cardiovascular phenotype |
| RS529890510 |
CACNA2D4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal cone dystrophy 4, Retinal cone dystrophy 4 |
| RS529890891 |
LRP1B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS529893298 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS529894272 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS529905904 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS529911259 |
SKIC3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS529912877 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS529914770 |
IFT172
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 10 with or without polydactyly, Retinitis pigmentosa 71 |
| RS529920914 |
EIF2AK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS529924080 |
TRPV6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperparathyroidism, transient neonatal |
| RS529924262 |
RASA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Capillary malformation-arteriovenous malformation 1, Cardiovascular phenotype |
| RS529940373 |
HOGA1
|
Health Risk |
Pathogenic |
— |
| RS529944004 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS529945350 |
PCCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, Inborn genetic diseases |
| RS529946385 |
PSMB8
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoinflammatory syndrome, Proteosome-associated autoinflammatory syndrome |
| RS529946415 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Hyperinsulinemic hypoglycemia |
| RS529954883 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS529957748 |
G6PC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS529960318 |
SNX14
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS529961953 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS529962978 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1F, PCDH15-related disorder |
| RS529972175 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS529977616 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS529979202 |
ENAM
|
Health Risk |
Pathogenic/Likely pathogenic |
Amelogenesis imperfecta type 1C, Amelogenesis imperfecta - hypoplastic autosomal dominant - local |
| RS529981007 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Primary dilated cardiomyopathy |
| RS529997128 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS529998714 |
NGLY1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of deglycosylation, Congenital disorder of deglycosylation |
| RS529998879 |
CLN5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 5 |
| RS530008202 |
SPEG
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS530013543 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Progressive familial heart block type IB |
| RS530021751 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS530032228 |
NAA60
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS530035386 |
IARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS530039573 |
VSX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS530040765 |
ALPK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS530045841 |
SLC25A46
|
Health Risk |
Pathogenic |
Neuropathy, hereditary motor and sensory |
| RS530055219 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS530059069 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS530062090 |
NAGLU
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-B |
| RS530064548 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS530066221 |
DTNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 1, Left ventricular noncompaction 1 |
| RS530071578 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS530073586 |
IKZF1
|
Health Risk |
Pathogenic |
Pancytopenia due to IKZF1 mutations, Pancytopenia due to IKZF1 mutations |
| RS530079482 |
CCBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hennekam lymphangiectasia-lymphedema syndrome 1, Hennekam lymphangiectasia-lymphedema syndrome 1 |
| RS530083972 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS530083993 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Alstrom syndrome |
| RS530087550 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS530087850 |
HTRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS530091118 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS530097220 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS530109812 |
SDR9C7
|
Health Risk |
Pathogenic |
Ichthyosis, congenital |
| RS530120957 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS530138013 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS530142447 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 2, Fraser syndrome 2 |
| RS530147851 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Branchiootorenal syndrome 1 |
| RS530152803 |
ABCC8
|
Health Risk |
Pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS530157547 |
BMPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary pulmonary hypertension, Inborn genetic diseases |
| RS530163400 |
KCNV2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone dystrophy with supernormal rod response, Cone dystrophy with supernormal rod response |
| RS530171166 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS530181166 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS530184161 |
SLC24A5
|
Health Risk |
Pathogenic |
— |
| RS530202330 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS530210018 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neuropathy |
| RS530213856 |
MDH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS530220412 |
ATP2B4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS530233908 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS530235885 |
SLC1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 6, Episodic ataxia type 6 |
| RS530250252 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS530251354 |
CYB5R3
|
Health Risk |
Likely pathogenic |
— |
| RS530255181 |
SHANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Schizophrenia 15, Phelan-McDermid syndrome |
| RS530256606 |
AHDC1
|
Health Risk |
Conflicting classifications of pathogenicity |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related disorder |
| RS530259403 |
PAX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Aniridia 1, Autosomal dominant keratitis |
| RS530269705 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS530270916 |
NKX2-5
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial septal defect 7, Cardiovascular phenotype |
| RS530285485 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate E, Focal segmental glomerulosclerosis 5 |
| RS530286781 |
FCHO1
|
Health Risk |
Pathogenic |
Severe congenital neutropenia, Immunodeficiency 76 |
| RS530287837 |
CTSA
|
Health Risk |
Pathogenic |
Combined deficiency of sialidase AND beta galactosidase, Combined deficiency of sialidase AND beta galactosidase |
| RS530291008 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS530291076 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, COL7A1-related disorder |
| RS530300374 |
OBSL1
|
Health Risk |
Pathogenic |
— |
| RS530310740 |
SOX17
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS530314472 |
TREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS530318278 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS530318579 |
NPHS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS530319460 |
CNGB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS530322096 |
C1QTNF5;MFRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Late-onset retinal degeneration, Isolated microphthalmia 5 |
| RS530337132 |
SBF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS530338718 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS530348521 |
PLA2G6
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile neuroaxonal dystrophy, Autosomal recessive Parkinson disease 14 |
| RS530361602 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Developmental and epileptic encephalopathy |
| RS530387460 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS530391015 |
INF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Focal segmental glomerulosclerosis, Proteinuria |
| RS530393871 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS530395989 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS530403338 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2Q, Epidermolysis bullosa simplex with nail dystrophy |